[Monoclonal antibody metabolism during the growth of hybridoma cells]. 1988

O S Morenkov, and Iu A Mantsygin, and E I Lezhenev

Metabolism of monoclonal antibodies (MAb) during the growth of mouse hybridoma, producing MAb to phage lambda, has been studied. It was shown that the specific production of MAb decreased by 25-35% in the stationary phase of growth in comparison with the middle of the exponential growth phase, which was associated with the decrease in the rate of MAb synthesis. The secretion kinetics of MAb did not change during the growth of hybridoma cells. MAb did not degrade inside the cells and in the culture medium after being secreted. The ratio of the synthesis rate of MAb to that of cellular proteins increased from 7-10% in the exponential growth phase to 14-18% in the stationary phase, which points to a specific regulation of MAb synthesis in comparison with cellular proteins. Possible regulation mechanisms for synthesis of MAb and cellular proteins during the growth of hybridoma cells are discussed.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D010582 Bacteriophage lambda A temperate inducible phage and type species of the genus lambda-like viruses, in the family SIPHOVIRIDAE. Its natural host is E. coli K12. Its VIRION contains linear double-stranded DNA with single-stranded 12-base 5' sticky ends. The DNA circularizes on infection. Coliphage lambda,Enterobacteria phage lambda,Phage lambda,lambda Phage
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
November 1998, Cytotechnology,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
January 1986, Methods in enzymology,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
November 1990, Journal of biotechnology,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
January 1988, Biotechnology advances,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
June 1992, Enzyme and microbial technology,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
July 1994, Biotechnology and bioengineering,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
October 1992, Annals of the New York Academy of Sciences,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
January 1994, Cytotechnology,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
December 1991, Journal of immunological methods,
O S Morenkov, and Iu A Mantsygin, and E I Lezhenev
July 1983, Journal of immunological methods,
Copied contents to your clipboard!